Outcomes of diabetic patients with acute coronary syndromes treated with aspirin in primary prevention

http://hdl.handle.net/10400.1/26563

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Outcomes of diabetic patients with acute coronary syndromes treated with aspirin in primary prevention.pdf		689.29 KB	Adobe PDF	Download

Authors

Espirito Santo, M.

Abstract(s)

The use of aspirin in primary prevention (PP) remains a matter of international debate. In type 2 diabetes mellitus (DM2) patients with high/very high cardiovascular (CV) risk, low dose aspirin may be considered for PP (class IIb, evidence level A) in european guidelines in the absence of hemorrhagic contraindication.

URI

http://hdl.handle.net/10400.1/26563

Publisher

Oxford University Press

DOI

10.1093/eurheartj/ehad655.2564

Collections

ULS_10.2-MED-Conferências

CC License

Altmetrics